Compugen | CGEN - Ativo Circulante





Ativo Circulante Alterar Data
Arca Biopharma USD 343.86M 11.31M 2025-12
aTyr Pharma USD 245.8M 152.79M 2025-12
Bio Path USD 663K 17K 2025-09
Brainstorm Cell Therapeutics USD 508K 1.01M 2025-09
Cara Therapeutics USD 43.13M 4.18M 2025-06
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 148.02M 59.1M 2025-12
Immunic USD 39.27M 20.57M 2025-09
Infinity Pharmaceuticals USD 19.91M 8.46M 2023-06
Minerva Neurosciences USD 83.1M 70.08M 2025-12
RedHill Biopharma USD 12.56M 644K 2025-06
TherapeuticsMD USD 11.82M 303K 2024-06